On August 24, 2009
Galderma Distributed Bogus PI for Skin Drug, FDA Claims
Galderma Labs distributed a bogus product label for its Tri-Luma Cream that falsely claimed the drug was for long-term use and failed to note that it can cause birth defects if used by pregnant women, the FDA said. Tri-Luma, for hyperpigmenation, is approved only for short-term use and can cause pregancy risks
0 Comments